文献速递胸部心血管MRCT

PREFUL-MRI鉴别PAH与CTEPH的价值:横断面观察研究

What is the difference between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension on phase-resolved functional lung MRI? A cross-sectional observational study.
PubMed 文献 · Eur Radiol · 2026-01-13

结果显示PREFUL-MRI视觉评估鉴别CTEPH的敏感度70%、特异度38%,低于V/Q SPECT/CT的95%和95%。CTEPH较PAH灌注缺损更重,灌注缺损百分比与肺血管阻力正相关,PREFUL-MRI更适合功能评价而非初筛鉴别。

要点

  • PREFUL-MRI视觉鉴别CTEPH效能低,不能替代V/Q SPECT/CT做亚型初筛。
  • CTEPH灌注缺损重于PAH,QDPexclusive 51.9%对24.4%,p<0.001。
  • QDPexclusive与PVR正相关(ρ=0.313,p=0.031),可反映血流动力学负荷。

核心结论

  • PREFUL-MRI视觉评估不能可靠区分PAH与CTEPH,但CTEPH灌注缺损负荷更大。
  • PREFUL-MRI更适合PH确诊后的功能性评价,不宜用于初始病因鉴别。

研究设计与样本

  • 患者均在1周内完成PREFUL-MRI、V/Q SPECT/CT及右心导管检查(PAH 26例,CTEPH 27例)。
  • PREFUL-MRI采用自由呼吸快速扰相梯度回波序列生成灌注图与通气图;图像由4名设盲阅片者判读。

关键影像表现/征象

  • 所有PH患者在PREFUL灌注图上均表现为多发灌注缺损。
  • CTEPH患者PREFUL灌注图上灌注缺损范围大于PAH,灌注缺损分布更重。

诊断标准与关键数值

  • PREFUL视觉评估鉴别CTEPH:敏感度70%,特异度38%;V/Q SPECT/CT为敏感度95%,特异度95%。
  • CTEPH与PAH灌注参数:QDPexclusive中位值51.9%对24.4%,p<0.001;QDPtotal 58.4%对30.85%,p<0.001。
  • CTEPH与PAH平均灌注:2.8%对3.9%,p=0.003;QDPexclusive代表有灌注缺损但无通气缺损区域占比,QDPtotal代表总体灌注缺损百分比。
  • 全队列中QDPexclusive与PVR正相关(ρ=0.313,p=0.031)。

临床应用与阅片要点

  • 阅片时PREFUL灌注图上多发灌注缺损不能直接提示CTEPH,PAH患者也可出现。
  • PREFUL定量灌注参数可用于PH确诊后的血流动力学严重度随访,无需造影剂和辐射。
  • 初始怀疑CTEPH时仍应首选V/Q SPECT/CT,PREFUL-MRI不宜单独用于病因分型。

局限性

  • 单中心回顾性研究,样本量较小,存在选择偏倚。
  • 所有患者均表现为多发灌注缺损,视觉判读鉴别效能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess whether phase-resolved functional lung MRI (PREFUL-MRI) can differentiate pulmonary arterial hypertension (PAH) from chronic thromboembolic pulmonary hypertension (CTEPH) and to compare PREFUL-derived perfusion and ventilation characteristics between the two entities.

MATERIALS AND METHODS: In this single-center study (January 2024-March 2025), patients with pulmonary hypertension (PH) who underwent PREFUL-MRI, ventilation/perfusion single-photon emission CT/CT (V/Q SPECT/CT), and right-heart catheterization within 1 week were retrospectively enrolled. PREFUL-MRI was acquired with a free-breathing fast spoiled gradient echo sequence to generate perfusion and ventilation maps. PREFUL maps and V/Q SPECT/CT were assessed by four blinded readers. Quantitative PREFUL parameters were compared between PAH and CTEPH, and correlations with hemodynamics were analyzed.

RESULTS: Fifty-three PH patients were included (PAH 26, CTEPH 27). All manifested multiple perfusion defects on PREFUL maps. Visual assessment with PREFUL yielded 70% sensitivity and 38% specificity for CTEPH, lower than V/Q SPECT/CT (sensitivity 95%, specificity 95%). CTEPH had higher perfusion defect percentage and lower mean perfusion than PAH (median QDPexclusive 51.9% vs. 24.4%, p < 0.001; QDPtotal 58.4% vs. 30.85%, p < 0.001; mean perfusion 2.8% vs. 3.9%, p = 0.003). QDPexclusive represents areas with perfusion defects but without ventilation defects, whereas QDPtotal indicates the overall perfusion defect percentage. Across the cohort, QDPexclusive correlated positively with pulmonary vascular resistance (PVR) (ρ = 0.313, p = 0.031).

CONCLUSIONS: PREFUL-MRI did not reliably distinguish PAH from CTEPH on visual assessment, although CTEPH exhibited a larger perfusion defect burden. It may be more suitable for functional evaluation of PH rather than for initial differential diagnosis.

KEY POINTS: QuestionCan phase-resolved functional lung MRI (PREFUL-MRI) noninvasively distinguish pulmonary arterial hypertension (PAH) from chronic thromboembolic pulmonary hypertension (CTEPH), and reflect their hemodynamic severity? FindingsPREFUL-MRI showed limited visual discrimination compared to V/Q SPECT/CT; CTEPH exhibited more severe perfusion defects; perfusion defect percentage correlated with pulmonary vascular resistance. Clinical relevancePREFUL-MRI provides radiation- and contrast-free perfusion metrics reflecting hemodynamic burden in pulmonary hypertension. Though suboptimal for initial discrimination in disease subtypes, it supports functional evaluation once the diagnosis is established.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu, Du, Li, et al. What is the difference between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension on phase-resolved functional lung MRI? A cross-sectional observational study. Eur Radiol. 2026. PMID: 41528476. doi:10.1007/s00330-025-12271-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。